(Head Office: Chiyoda-ku, Tokyo, President: Fabrice Egros, hereinafter referred to as UCB Japan), Daiichi Pharmaceutical Co., Ltd.(Head Office: Chuo-ku, President: Kiyoshi Morita, hereinafter referred to as Daiichi, fully owned by DAIICHI SANKYO COMPANY, LIMITED) and Glaxo Smith Kline K. (President: Marc Dunoyer, Head Office: Shibuya-ku, Tokyo, hereinafter referred to as GSK) announced that on July 13, Zyrtec tablet, Zyrtec Dry Syrup 1.25% will be manufactured by UCB Japan and distributed by Daiichi and GSK. Launch of New Formulation Zyrtec® Dry Syrup 1.25% selective H1 receptor antagonist, anti-allergic agent UCB Japan Co., Ltd.Ask a doctor before use if you have liver or kidney disease (Your doctor should determine if you need a different dose).Ask a doctor or pharmacist before use if you are taking tranquilizers or sedatives.All third-party trademarks are property of their respective owners.This website contains current product information and may differ from the information on the product packaging you may have.
It is not known whether Zyrtec will harm an unborn baby.
Ask a doctor before using this medicine if you are pregnant.
Get allergy relief that starts working faster than Claritin® on the first day you take it.* *ZYRTEC® starts working at hour 1 and Claritin® starts working at hour 3 based on the first dose on the first day of a 2-day study in two pollen chamber studies.
Tell your doctor if you regularly use other medicines that make you sleepy (such as other cold or allergy medicine, narcotic pain medicine, sleeping pills, muscle relaxers, and medicine for seizures, depression, or anxiety). Call your doctor if your symptoms do not improve, if they get worse, or if you also have a fever.
You should not use Zyrtec if you are allergic to cetirizine.